Allergy/Asthma

PHOENIX — A fecal microbiota transplant from healthy donors enabled patients with severe peanut allergy to safely eat small amounts of peanut, according to a presentation at American Academy of Allergy, Asthma & Immunology Annual Meeting.

PHOENIX — Certain phenotypes are associated with difficult-to-control asthma in urban children, which may be characterized by specific early-life factors and patterns of nasal epithelial cell gene expression, according to a speaker here.

Children with atopic dermatitis generally experienced the most intense itching in the early evening or bedtime, approximately 3 hours before they fell asleep, according to a study published in Annals of Allergy, Asthma & Immunology.

Pediatric allergy clinics can use telemedicine to increase accessibility, with subsequent in-person visits scheduled for necessary testing, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Simplification from twice-daily to once-daily dosing of inhaled corticosteroids for asthma correlated with better medication adherence in children, according to a study published in Annals of Allergy, Asthma & Immunology.

Parents whose children are being evaluated for peanut and other food allergies may be anxious during testing, but deep breathing may help them cope, report a pair of studies published in Annals of Allergy, Asthma & Immunology.

Oral immunotherapy with or without probiotic adjuvants conferred sustained unresponsiveness to peanut among allergic children, according to a randomized phase 2b study published in The Lancet Child & Adolescent Health.

Levels of food proteins in breastmilk appeared much lower than the dose required to elicit an IgE-mediated allergic reaction among infants, according to a systematic review in The Journal of Allergy and Clinical Immunology: In Practice.

Although cases of pediatric food allergy anaphylaxis increased in Australia over the last 2 decades, the rate of increase slowed following the release of new guidelines, according to data in The Journal of Allergy and Clinical Immunology.

In a real-world setting, peanut oral immunotherapy was safer in infants aged 12 months or younger than in children aged 1 to 5 years, according to recent data.